Pain - I agree that this PR answered a whole lot of questions especially about the Morph. You also noticed that the PR had to be approved. Now lets see where we go from here.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.